Intellectus Partners, LLC Corcept Therapeutics Inc Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Intellectus Partners, LLC holds 54,859 shares of CORT stock, worth $3.29 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

54,859

Holding current value

$3.29 Million

% of portfolio

0.66%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$29.51 - $46.26 $1.62 Million - $2.54 Million	54,859 New	54,859 $2.54 Million
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $15.1 Million - $24.6 Million	900,000 New	900,000 $3,000
Q1 2020 May 14, 2020	SELL	$10.11 - $14.04 $114,243 - $158,652	-11,300 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$12.06 - $16.96 $27,738 - $39,008	-2,300 Reduced 16.91%	11,300 $137,000
Q3 2019 Oct 11, 2019	BUY	$10.41 - $14.66 $16,177 - $22,781	1,554 Added 12.9%	13,600 $192,000
Q2 2019 Aug 08, 2019	BUY	$9.78 - $12.76 $9,780 - $12,760	1,000 Added 9.05%	12,046 $134,000
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $75,505 - $118,264	-7,528 Reduced 40.53%	11,046 $130,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $1.35 Million - $2.06 Million	-119,800 Reduced 86.58%	18,574 $248,000
Q3 2018 Nov 15, 2018	BUY	$12.27 - $15.65 $18,405 - $23,475	1,500 Added 1.1%	138,374 $1.94 Million
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $2,723 - $3,504	178 Added 0.13%	136,874 $2.15 Million
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $32,827 - $57,375	-2,250 Reduced 1.62%	136,696 $2.25 Million
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $157,700 - $207,200	-10,000 Reduced 6.71%	138,946 $2.51 Million
Q3 2017 Nov 14, 2017	SELL	$12.3 - $19.3 $12,915 - $20,265	-1,050 Reduced 0.7%	148,946 $2.88 Million
Q2 2017 Aug 15, 2017	BUY	N/A	149,996	149,996 $1.77 Million

Others Institutions Holding CORT

# of Institutions

349

Shares Held

85.5M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Corcept Therapeutics Inc Transaction History